| 产品描述: | DX600 is a selective ACE2 specific inhibitor (KD: 1.3 nM), and does not cross-react with ACE. DX600 exacerbates diabetes-induced cardiovascular dysfunction and the increase in cardiac and renal NOX activity. |
| 体外研究: |
DX600 (1 μM) 可抑制 47% 的 rhACE2 活性,pIC50 为 8.0。 DX600 (10 μM) 可抑制 42% 的人类 MNC (单核细胞) 中 ACE2 活性。 DX600 (100 nM,4 小时) 会降低 NR 8383 细胞的生长,并增加上清液中 TNF-a 和 IL-6 的含量 (在存在 LPS 和 osthole 的情况下)。 |
| 参考文献: |
1. Liao K, et al. Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2).J Immunol Methods. 2013 Mar 29;389(1-2):52-60. 2. Yousif MH, et al. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes. Pharmacol Res. 2012 Sep;66(3):269-75. 3. Svilenov HL, et al. Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2. Commun Biol. 2023 Apr 8;6(1):386. 4. Joshi S, et al. Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells. Eur J Pharmacol. 2016 Mar 5;774:25-33. 5. Fraga-Silva RA, et al. ACE2 activation promotes antithrombotic activity. Mol Med. 2010 May-Jun;16(5-6):210-5. |
| 保存条件: |
-20°C, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.325 ml |
1.626 ml |
3.253 ml |
| 5 mM |
0.065 ml |
0.325 ml |
0.651 ml |
| 10 mM |
0.033 ml |
0.163 ml |
0.325 ml |
| 50 mM |
0.007 ml |
0.033 ml |
0.065 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |